Please assess the completion status of the following clinical trial:

Trial Title: Effect of Ciclesonide on Exercise Induced Bronchoconstriction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* stable asthma not on maintenance asthma medications~* exercise induced bronchoconstriction on dry air exercise challenge.~Exclusion Criteria:~* other significant co-morbidity or treatments that might interfere with the conduct or results of the study~* fail to return to baseline after a maximum washout period of 8 weeks~* unable to perform the procedures of the study

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 30 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): ciclesonide 50 and 200ug
- 2 (Type: ACTIVE_COMPARATOR): ciclesonide 100ug and 400ug

Based on this trial design, predict the completion outcome and termination type (if applicable).